A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
- PMID: 31088844
- DOI: 10.1158/2326-6066.CIR-18-0500
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
Abstract
Natural killer (NK) cell activity is essential for initiating antitumor responses and may be linked to immunotherapy success. NK cells and other innate immune components could be exploitable for cancer treatment, which drives the need for tools and methods that identify therapeutic avenues. Here, we extend our gene-set scoring method singscore to investigate NK cell infiltration by applying RNA-seq analysis to samples from bulk tumors. Computational methods have been developed for the deconvolution of immune cell types within solid tumors. We have taken the NK cell gene signatures from several such tools, then curated the gene list using a comparative analysis of tumors and immune cell types. Using a gene-set scoring method to investigate RNA-seq data from The Cancer Genome Atlas (TCGA), we show that patients with metastatic cutaneous melanoma have an improved survival rate if their tumor shows evidence of NK cell infiltration. Furthermore, these survival effects are enhanced in tumors that show higher expression of genes that encode NK cell stimuli such as the cytokine IL15 Using this signature, we then examine transcriptomic data to identify tumor and stromal components that may influence the penetrance of NK cells into solid tumors. Our results provide evidence that NK cells play a role in the regulation of human tumors and highlight potential survival effects associated with increased NK cell activity. Our computational analysis identifies putative gene targets that may be of therapeutic value for boosting NK cell antitumor immunity.
©2019 American Association for Cancer Research.
Similar articles
-
Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.Comput Math Methods Med. 2020 Nov 16;2020:8836493. doi: 10.1155/2020/8836493. eCollection 2020. Comput Math Methods Med. 2020. PMID: 33273963 Free PMC article.
-
Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response.Arch Dermatol Res. 2024 May 25;316(6):262. doi: 10.1007/s00403-024-03080-3. Arch Dermatol Res. 2024. PMID: 38795156
-
Comprehensive single-cell and bulk transcriptomic analyses to develop an NK cell-derived gene signature for prognostic assessment and precision medicine in breast cancer.Front Immunol. 2024 Oct 23;15:1460607. doi: 10.3389/fimmu.2024.1460607. eCollection 2024. Front Immunol. 2024. PMID: 39507529 Free PMC article.
-
New avenues for melanoma immunotherapy: Natural Killer cells?Scand J Immunol. 2020 Apr;91(4):e12861. doi: 10.1111/sji.12861. Epub 2020 Feb 9. Scand J Immunol. 2020. PMID: 31879979 Review.
-
The Immunology of Melanoma.Clin Lab Med. 2017 Sep;37(3):449-471. doi: 10.1016/j.cll.2017.06.001. Clin Lab Med. 2017. PMID: 28802495 Review.
Cited by
-
Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis.Endocrine. 2023 Jan;79(1):171-179. doi: 10.1007/s12020-022-03218-1. Epub 2022 Nov 12. Endocrine. 2023. PMID: 36370152 Free PMC article.
-
Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients.Front Immunol. 2021 May 10;12:659444. doi: 10.3389/fimmu.2021.659444. eCollection 2021. Front Immunol. 2021. PMID: 34040608 Free PMC article.
-
CAR NK Cell Therapy for the Treatment of Metastatic Melanoma: Potential & Prospects.Cells. 2023 Nov 30;12(23):2750. doi: 10.3390/cells12232750. Cells. 2023. PMID: 38067178 Free PMC article. Review.
-
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies.Front Immunol. 2022 Aug 12;13:910595. doi: 10.3389/fimmu.2022.910595. eCollection 2022. Front Immunol. 2022. PMID: 36045670 Free PMC article. Review.
-
Leveraging Public Single-Cell and Bulk Transcriptomic Datasets to Delineate MAIT Cell Roles and Phenotypic Characteristics in Human Malignancies.Front Immunol. 2020 Jul 31;11:1691. doi: 10.3389/fimmu.2020.01691. eCollection 2020. Front Immunol. 2020. PMID: 32849590 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
